Neuren Pharmaceuticals Ltd (neu) Logo

Neuren Pharmaceuticals Ltd (NEU)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

NEU ASX Chart

Snapshot

Neuren Pharmaceuticals Limited (NEU) is a biopharmaceutical company developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. Recognising the urgent unmet need, all programs have been granted orphan drug designation in the United States.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) +42.69%
vs ASX 200 (1yr) -3.89%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 275 of 2,340
Sector Rank 17 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies EBO / SIG / CSL
EPS $0.233
DPS $0.00
Book Value Per Share $2.679

Broker Consensus

NEU is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Auckland New Zealand 1141
Website www.neurenpharma.com
Registry MUFG Corporate Markets
Auditor Grant Thornton New Zealand Audit Limited
Date Listed 3 Feb 2005

Upcoming Calendar (Forecasted)

Date Event
26/08/2026 Report (Interim)
26/02/2027 Report (Prelim)
23/04/2027 Report (Annual)

Former Company Names

  • Neuren Pharmaceuticals Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

NEU directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
05/03/26 Joseph(Joe) Basile Buy +12,300 $12.34 $151,782 On-market trade
08/09/25 Jonathan (Jon) Pilcher Sell +398,207 $20.00 ($7,964,140) On-market trade
22/07/25 Jonathan (Jon) Pilcher Buy +1,500,000 $1.84 $2,760,000 Conversion of securities
22/07/25 Jonathan (Jon) Pilcher Exercise 1,500,000 $1.84 $2,760,000 Conversion of securities
16/04/25 Joseph(Joe) Basile Buy +14,500 $10.56 $153,158 On-market trade
16/08/24 Joseph(Joe) Basile Buy +6,406 $15.73 $100,766 On-market trade
11/06/24 Joseph(Joe) Basile Buy +5,000 $19.49 $97,450 On-market trade
13/09/23 Joseph(Joe) Basile Buy +5,000 $11.99 $59,950 On-market trade
14/06/23 Trevor Scott Sell +1,175,000 $13.00 ($15,275,000) On-market trade
18/10/21 Dianne Angus Buy +30,000 $1.98 $59,316 On-market trade
08/10/21 Patrick Davies Buy +14,634 $2.05 $30,000 Participation in share purchase plan
08/10/21 Jonathan (Jon) Pilcher Buy +7,317 $2.05 $15,000 Participation in share purchase plan
08/10/21 Jenny Harry Buy +9,756 $2.05 $20,000 Participation in share purchase plan
24/06/21 Patrick Davies Buy +43,694 $1.40 $61,172 On-market trade
15/06/21 Jonathan (Jon) Pilcher Buy +19,039 $1.31 $25,000 On-market trade
17/02/21 Patrick Davies Buy +35,211 $1.42 $50,175 On-market trade
11/08/20 Trevor Scott Transfer 400,000 $1.29 $514,000 Off-market transfer
07/08/20 Patrick Davies Buy +21,428 $1.40 $30,000 Participation in share purchase plan
29/05/20 Jenny Harry Buy +5,823 $1.71 $9,955 On-market trade
28/05/20 Patrick Davies Buy +28,655 $1.77 $50,719 On-market trade
26/05/20 Richard Treagus Transfer 1,979,163 $1.68 $3,324,993 Off-market transfer
26/05/20 Richard Treagus Transfer 1,979,163 $1.68 $3,324,993 Off-market transfer
25/03/20 Patrick Davies Buy +45,455 $1.15 $52,046 On-market trade
19/03/20 Patrick Davies Buy +5,911 $1.11 $6,560 On-market trade
31/12/18 Lawrence (Larry) Glass Transfer 1,064,517 $1.40 $1,490,324 Off-market transfer
31/12/18 Lawrence (Larry) Glass Transfer 1,064,517 $1.40 $1,490,324 Off-market transfer
28/09/18 Richard Treagus Buy +16,000 $1.24 $19,840 On-market trade
14/08/18 Patrick Davies Buy +69,646 $1.44 $100,001 On-market trade
10/08/18 Jenny Harry Buy +14,084 $1.46 $20,584 On-market trade
30/05/18 Richard Treagus Sell +2,000,000 $0.78 ($1,560,000) As advised by the company
30/05/18 Richard Treagus Transfer 1,498,393 $3.06 $4,585,083 Off-market transfer
29/08/17 Trevor Scott Issued 9,677,419 $0.062 $600,000 Issue of securities
29/08/17 Trevor Scott Transfer 20,000,000 $0.061 $1,220,000 Off-market transfer
29/08/17 Trevor Scott Transfer 20,000,000 $0.061 $1,220,000 Off-market transfer
29/08/17 Lawrence (Larry) Glass Issued 1,290,323 $0.062 $80,000 Issue of securities
29/08/17 Richard Treagus Issued 1,290,323 $0.062 $80,000 Issue of securities
31/08/16 Richard Treagus Buy +9,615,385 $0.044 $423,077 Conversion of securities
31/08/16 Richard Treagus Exercise 9,615,385 $0.044 $423,077 Conversion of securities
Show All

Director Interests

The current holdings of NEU directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Joseph(Joe) Basile 16/03/2026 36,800 11,406 N/A N/A
Patrick Davies 16/03/2026 N/A 264,634 N/A N/A
Jenny Harry 16/03/2026 N/A 29,663 N/A N/A
Jonathan (Jon) Pilcher 16/03/2026 1,500,000 N/A N/A N/A
Dianne Angus 16/03/2026 30,000 N/A N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Mar 16, 2026.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 22,145,477 17.50%
Citicorp Nominees Pty Limited 13,834,099 10.93%
J P Morgan Nominees Australia Pty Limited 10,413,515 8.23%
BNP Paribas Noms Pty Ltd 5,238,479 4.14%
Cameron Richard Pty Ltd 3,914,900 3.09%
Stuart Andrew Pty Ltd 2,814,100 2.22%
Smithley Super Pty Ltd 1,577,000 1.25%
Linwierik Super Pty Ltd 1,560,000 1.23%
BNP Paribas Nominees Pty Ltd (i) 1,520,378 1.20%
Jonathan Pilcher 1,500,000 1.19%
Sharesies Australia Nominee Pty Limited 1,323,965 1.05%
Southern Capital Limited 1,103,947 0.87%
Mjhft Pty Ltd 900,000 0.71%
Essex Castle Limited 843,731 0.67%
First Colbyco Pty Ltd 800,000 0.63%
BNP Paribas Nominees Pty Ltd 714,490 0.56%
Dr Robin Lance Congreve 641,637 0.51%
Emancipayte Pty Ltd 463,151 0.37%
BNP Paribas Nominees Pty Ltd (ii) 463,066 0.37%
Mr He Zhao 424,600 0.34%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 7,441 2,888 637 790 115 11,871

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
State Street Corporation and subsidiaries 16/03/2026 6,412,618 5.01
Vanguard Group 16/03/2026 6,492,295 5.02

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $14.11 30 June
2024 $21.27 28 June
2023 $12.25 30 June
2022 $3.80 30 June
2021 $1.63 30 June
2020 $1.37 30 June
2019 $1.15 28 June
2018 $2.97 29 June
2017 $0.068 30 June
2016 $0.055 30 June
2015 $0.079 30 June
2014 $0.083 30 June
NEU Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.